The Asceniv market is witnessing steady growth over the forecast period, supported by increasing pid diagnosis rates, shift toward home infusion models.
Read More
The Arcalyst (rilonacept) market is witnessing steady growth over the forecast period, supported by growing diagnosis of autoinflammatory syndromes, expansion into additional indications.
Read More
The Aralast, Aralast Np market is witnessing steady growth over the forecast period, supported by increasing early aatd diagnosis rates, expansion of rare respiratory disease awareness.
Read More
The Aplisol market is witnessing steady growth over the forecast period, supported by renewed tb surveillance efforts, migration related screening needs.
Read More
The Apidra market is witnessing steady growth over the forecast period, supported by rising type 2 diabetes incidence, expanding geriatric population.
Read More
The Anthrasil market is witnessing steady growth over the forecast period, supported by continued public health preparedness funding, expansion of biodefense stockpiles.
Read More
The Anthim market is witnessing steady growth over the forecast period, supported by continued biodefense investment, rising focus on pandemic and biosecurity readiness.
Read More
The Andexxa (Ondexxya) market is witnessing steady growth over the forecast period, supported by growth in cardiovascular disease prevalence, increased anticoagulant prescriptions.
Read More
The Anavip market is witnessing steady growth over the forecast period, supported by increasing awareness of effective snakebite treatment, expansion of emergency medical infrastructure.
Read More
The Anascorp market is witnessing steady growth over the forecast period, supported by climate driven venom spread, improved emergency access.
Read More